PRKCA and endometrial cancer: An interesting finding indicates that in patient samples, animal models, and human endometrial cancer cell lines, PKCα exhibited a key tumor-suppressive role mediated by its ability to suppress the PI3K/Akt signaling pathway by activating PP2A [168,169].